Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M; Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Wright A, et al. Among authors: van soolingen d, van deun a. Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15. Lancet. 2009. PMID: 19375159 Free article. Review.
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Souleymane MB, Kadri S, Piubello A, Tsoumanis A, Soumana A, Issa H, Amoussa AK, Van Deun A, Lynen L, de Jong BC, Decroo T. Souleymane MB, et al. Among authors: van deun a. Int J Infect Dis. 2023 Aug;133:78-81. doi: 10.1016/j.ijid.2023.05.002. Epub 2023 May 5. Int J Infect Dis. 2023. PMID: 37150352 Free article. Clinical Trial.
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M; WHO/International Union Against Tuberculosis And Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Aziz MA, et al. Among authors: van deun a. Lancet. 2006 Dec 16;368(9553):2142-54. doi: 10.1016/S0140-6736(06)69863-2. Lancet. 2006. PMID: 17174706
Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Shah NS, et al. Among authors: van deun a. Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400. Emerg Infect Dis. 2007. PMID: 17552090 Free PMC article.
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania.
Chonde TM, Doulla B, van Leth F, Mfinanga SG, Range N, Lwilla F, Mfaume SM, van Deun A, Zignol M, Cobelens FG, Egwaga SM. Chonde TM, et al. Among authors: van leth f, van deun a. BMC Public Health. 2008 Dec 30;8:427. doi: 10.1186/1471-2458-8-427. BMC Public Health. 2008. PMID: 19116022 Free PMC article.
National anti-tuberculosis drug resistance study in Tanzania.
Chonde TM, Basra D, Mfinanga SG, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F. Chonde TM, et al. Among authors: van leth f, van deun a. Int J Tuberc Lung Dis. 2010 Aug;14(8):967-72. Int J Tuberc Lung Dis. 2010. PMID: 20626940
159 results